Our demonstration that 2,4,6-THBA inhibits cell growth in cancer cells expressing functional SLC5A8 suggests that such a phenomenon may indeed exist in vivo and may contribute to its anti-cancer effects against CRC. Here, SLC5A8 is linked to cancer.